iSpeak Blog
Quality and regulatory teams face a constant stream of external signals: draft and final guidance, inspection trends, revised standards, pharmacopeial updates, and industry commentary. Monitoring these signals is routine; deciding what to do with them is not. The common practice for most companies is to disseminate information broadly regarding updates but apply differing levels of scrutiny...